Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Allergy and Asthma Following Children Who Were Fed Supplemented Infant Formula

This study has been completed.
National Institutes of Health (NIH)
Information provided by:
Mead Johnson Nutrition Identifier:
First received: August 22, 2008
Last updated: NA
Last verified: August 2008
History: No changes posted
Long-term cognitive outcome study of children who participated in randomized trials of LCP-supplemented formula during infancy.


Study Type: Observational

Resource links provided by NLM:

Further study details as provided by Mead Johnson Nutrition:

Primary Outcome Measures:
  • Prevalence of asthma and allergy related diagnosis in medical records during first 3 years of life. [ Time Frame: after first 3 years of life ]


Ages Eligible for Study:   up to 12 Months   (Child)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Study Population
children previously randomized in a clinical study consuming LCP-supplemented infant formula

Inclusion Criteria:

  • children previously randomized in a clinical study consuming LCP-supplemented infant formula

Exclusion Criteria:

  • children who did not previously participate in a randomized clinical study consuming LCP-supplemented infant formula
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00740974

United States, Texas
Retina Foundation of the Southwest
Dallas, Texas, United States, 75231
Sponsors and Collaborators
Mead Johnson Nutrition
National Institutes of Health (NIH)
  More Information Identifier: NCT00740974     History of Changes
Other Study ID Numbers: 8580 
Study First Received: August 22, 2008
Last Updated: August 22, 2008
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases processed this record on December 09, 2016